Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
128.4 USD | -0.71% | -1.60% | +17.68% |
02:36pm | US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine | RE |
May. 13 | Merck: phase 3 trial in melanoma halted | CF |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bullish | Bullish |
Resistance | 131.95 | 131.95 | 131.95 |
Spread/Res. | -2.92% | -2.92% | -2.92% |
Spread/Supp. | +2.43% | +11.01% | +11.01% |
Support | 125.06 | 115.39 | 115.39 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- MRK Stock
- Charts Merck & Co., Inc.